Adenocarcinoma of the prostate and rectum are common male pelvic cancers and may present synchronously or metachronously due to their anatomic proximity.
The treatment of rectal or prostate cancer (in particular surgery and/or radiotherapy) may alter the presentation, incidence and management should a metachronous tumour develop. This review focuses on the interaction between prostatic and rectal cancer diagnosis and management. We have restricted the scope of this large topic to general considerations, management of rectal cancer after prostate cancer treatment and vice versa, management of synchronous disease and cancer follow-up issues.
Written by:
Nash GF, Turner KJ, Hickish T, Smith J, Chand M, Moran BJ. Are you the author?
Department of Surgery, Poole Hospital, Longfleet Road, Poole, Dorset BH15 2JB, UK.
Reference: Ann R Coll Surg Engl. 2012 Oct;94(7):456-62.
doi: 10.1308/003588412X13373405384611
PubMed Abstract
PMID: 23031761
UroToday.com Prostate Cancer Section
